ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
AstraZeneca
A Respiratory Account Specialist at AstraZeneca in the UK is responsible for developing account strategies and engaging with NHS customers to improve respiratory patient outcomes and achieve regional sales targets. The role involves working across hospital and primary care settings, using various engagement channels and NHS datasets to identify opportunities.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
AstraZeneca didn’t post a salary, so this is our estimate from similar listings.
32% above the average for this role
Respiratory Account Specialist - Glasgow & Clyde, Dumfries & Galloway
lifelancer
Key Account and Access Manager UK
Cytokinetics
Respiratory Key Account Manager - North West England
sanofi us
Key Account Manager - Oncology (UK & Ireland)
Digital Biology
Respiratory Account Specialist
lifelancer
Key Account Manager, Infectious Diseases
Mundipharma